What Transformation Has the Blood Glucose Meters Market Undergone?
The blood glucose meters market has seen considerable growth due to a variety of factors.
• The market for blood glucose meters has seen a substantial expansion in the recent past. Its size is set to increase from $14.64 billion in 2024 to $16.5 billion in 2025, representing a compound annual growth rate (CAGR) of 12.7%.
Factors such as the escalating prevalence of diabetes, enhanced awareness of diabetes care, the rise in the elderly population, the growing trend of home healthcare, beneficial insurance coverage, and reimbursement policies as well as patient empowerment have contributed to the notable growth during the historical period.
What is the Forecasted Market Size and CAGR for the Blood Glucose Meters Market?
The blood glucose meters market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of blood glucose meters is anticipated to experience a swift expansion in the coming years. The market is predicted to reach $25.86 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%.
This expansion during the forecast period can be linked to the incorporation of continuous glucose monitoring (CGM), connectivity with smartphones, the application of artificial intelligence (AI), a concentration on wearable devices, and remote patient supervision. Key trends to watch for during this period are advancements in monitor devices, the inclusion of continuous glucose monitoring, connection to smartphones, miniaturization, and portability, insightful data analytics, telehealth, and distance monitoring.
What Are The Key Drivers Fueling Growth In The Blood Glucose Meters Market?
The escalating diabetes cases are propelling the expansion of the blood glucose meters market. Factors such as altered lifestyles, higher alcohol ingestion, sedentary activities, and unhealthy food choices have led to a global obesity epidemic. This significant rise in obesity contributes to a substantial increase in the acquisition of blood glucose meters. Obesity triggers fat tissues to emit an excessive number of fat molecules into the bloodstream, disrupting insulin-responsive cells and causing decreased insulin sensitivity, ultimately leading to diabetes. For example, in December 2022, the US government's National Health Service (NHS) made impressive progress in broadening the availability of sophisticated blood glucose monitor technologies. By year-end, around 200,000 diabetes sufferers were provided with continuous glucose monitoring (CGM) devices. This advancement presented a considerable rise, particularly advantageous for type 1 diabetes patients now equipped with improved resources for efficient management of their condition.
What Are The Principal Market Segments In The Global Blood Glucose Meters Healthcare Industry?
The blood glucose meters market covered in this report is segmented –
1) By Product Type: Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter
2) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
3) By End User: Hospitals, Home Care
Subsegments:
1) By Electrode Type Blood Glucose Meter: Strip-based Meters, Continuous Glucose Monitors (CGMs)
2) By Photoelectric Blood Glucose Meter: Reflectance Meters, Fluorescence Meters
Pre-Book The Blood Glucose Meters Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Blood Glucose Meters Market?
One of the key emerging trends in the blood glucose meters market is the introduction of new products. Market players are launching fresh products to diversify their range and solidify their stand in the marketplace. As an illustration, Swiss healthcare multinational, Roche, unveiled a novel point-of-care blood glucose monitor engineered for hospital professionals in January 2022. It comes with a companion tool designed like a touchscreen smartphone which comes with its own dedicated applications. American insulin management software firm, Glytec, provided the software for the device, the Glucommander insulin-dosing system, to streamline the complex process of managing a patient's blood sugar levels during their hospitalization.
Who Are the Key Players in the Blood Glucose Meters Market?
Major companies operating in the blood glucose meters market include:
• Roche Diagnostics
• Abbott Laboratories
• Medtronic
• Bayer Healthcare
• LifeScan Inc. (Johnson & Johnson)
• Ascensia Diabetes Care
• ARKRAY Inc.
• Dexcom Inc.
• Bionime Corporation
• Ypsomed AG
• Nova Biomedical
• ForaCare Inc.
• AgaMatrix Inc.
• Entra Health Systems
• i-SENS Inc.
• Prodigy Diabetes Care
• Infopia Co. Ltd.
• Omron Healthcare Inc.
• HMD Biomedical Inc.
• 77 Elektronika Kft
• Trividia Health Inc.
• Nipro Corporation
• Beijing Yicheng Bioelectronics Technology Co. Ltd.
• All Medicus Co. Ltd.
• Sinocare Inc.
• Bioland Technology.
What are the Regional Insights into the Blood Glucose Meters Market?
North America was the largest region in the global blood glucose meters market in 2024. Western Europe was the second-largest region in the blood glucose meters market. The regions covered in the blood glucose meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
